The April/May Board of Medicine Newsletter is available. Please click here or the image below to read more.
More Latest News
February 12, 2019
The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa. Continue reading